Neuroendocrine carcinoma of paranasal sinuses and nasal cavity is a rare and fast-growing cancer that develops from neuroendocrine cells, combining features of nerve cells and hormone-producing endocrine cells. Despite the presence of neuroendocrine cells in all organs and tissues of the body, neuroendocrine carcinoma developing in the area of the sinonasal cavity is a rather rare disease, which requires quick detection and specific treatment
Since neuroendocrine carcinoma of the nasal cavity and paranasal sinuses tends to grow rapidly and infiltrate surrounding structures, including the orbit, the skull base, and even the brain, early detection and a multidisciplinary approach are crucial for effective treatment. Nowadays, the treatment usually includes chemotherapy, radiation, and surgical interventions, depending on the individual case.
The multidisciplinary team in our Head and Neck Oncology Department at Tender Palm Hospital, Gomti Nagar, Lucknow, offers patients diagnosis and treatment for neuroendocrine carcinoma of the nose and paranasal sinuses.
A neuroendocrine carcinoma (NEC) is a malignant epithelial neoplasm characterized by high-grade differentiation and neuroendocrine differentiation. This tumor arises from cells capable of secreting the proteins and hormones specific to the nervous and endocrine systems.
Even though the majority of neuroendocrine tumors occur in the lungs and gastrointestinal tract, they can very rarely develop within the nasal cavity and paranasal sinuses. This type of tumor usually progresses faster than other types of sinonasal cancers.
Yes. Neuroendocrine carcinoma is an uncommon cancer. It belongs to the group of sinonasal malignancies.
This type of cancer is different from other cancers, such as squamous cell carcinoma, adenocarcinoma, olfactory neuroblastoma, and sinonasal undifferentiated carcinoma (SNUC). To diagnose this tumor, specialized pathological investigations are needed because of its clinical and imaging features that resemble those of other cancers.
The following subtypes of neuroendocrine carcinomas of the paranasal sinuses and nasal cavity are distinguished:
The following subtypes of neuroendocrine carcinomas of the paranasal sinuses and nasal cavity are distinguished:
Small cell neuroendocrine carcinoma is by far the most common and most aggressive type. It is composed of small, rapidly dividing cancer cells that require chemotherapy and radiotherapy in combination, while surgery is limited to selective cases.
Large cell neuroendocrine carcinoma is another high-grade tumor but differs from the small cell type in that it is composed of large cells with neuroendocrine features. This tumor type is less common in the sinonasal region and is managed using multimodality treatment.
They are very rarely encountered tumors within the nasal cavity and paranasal sinuses. As compared to neuroendocrine carcinomas, well-differentiated neuroendocrine tumors generally have a slow growth pattern and a favorable prognosis.
The exact cause of neuroendocrine carcinoma is unknown. This is caused by genetic changes leading to uncontrolled growth of neuroendocrine cells. The majority of patients do not have any known causes for developing this condition.
Unlike squamous cell carcinoma, smoking has not been conclusively linked with sinonasal neuroendocrine carcinoma.
Possible risk factors include:
Many individuals with this cancer do not have any underlying conditions that increase the risk of developing it.
Initial symptoms may mimic chronic sinus disease.
The most common symptoms include:
As the tumor continues to grow, symptoms will worsen because of structural invasion.
See your physician when you experience:
Early diagnosis is beneficial for developing an appropriate treatment plan.
An accurate diagnosis is achieved through clinical evaluation, imaging studies, and specific pathology.
The physician reviews the patient's symptoms and medical history and conducts a thorough examination of the head and neck.
The procedure allows visualizing the tumor directly and obtaining a biopsy sample.
Imaging studies are necessary to evaluate the size and extent of the tumor.
Some possible tests are:
MRI is particularly helpful in evaluating the orbital, skull base, and intracranial involvement of the tumor. PET-CT is used to evaluate the distant spread of the cancer.
It is important for making a diagnosis.
The specimen is examined:
Common neuroendocrine markers are:
Other markers, such as cytokeratins and Ki-67, are useful for confirming the diagnosis and assessing tumor proliferation. The pathologist can also use additional markers for differentiating between neuroendocrine carcinoma, olfactory neuroblastoma, sinonasal undifferentiated carcinoma, lymphoma, and melanoma.
These tumors are typically staged using the TNM (Tumor, Node, Metastasis) staging system.
The TNM staging system considers:
Proper staging helps make treatment decisions and provides a prognosis.
The treatment modality of choice will depend on the specific subtype, stage, and health status of the patient. As these tumors are highly aggressive, multiple treatment modalities are needed in management.
Chemotherapy is one of the mainstays of treatment, especially when treating small cell neuroendocrine carcinoma. Platinum chemotherapy in combination with etoposide is widely used for high-grade neuroendocrine carcinoma.
Radiotherapy is often used in conjunction with chemotherapy to enhance control of the disease at the local level. Radiotherapy can be done post-operatively or as definitive therapy when surgery cannot be performed.
In some patients with localized tumors, surgery could be an option. The type of surgical procedure may vary from endoscopic resection of the tumor to open surgery with involvement of the skull base.
The therapy has revolutionized the management of various advanced forms of neuroendocrine tumors, especially small cell lung cancer. Even though the application of immunotherapy for sinonasal neuroendocrine carcinoma is still unclear, some patients with recurrent or metastatic disease may receive this treatment depending on the existing data, biomarkers, and multidisciplinary review.
Certain individuals with localized disease may achieve remission or even a cure with a multimodal treatment approach.
The chances of a cure depend on the following factors:
Early detection is the best chance of successfully managing the disease.
Neuroendocrine carcinoma is a relatively aggressive form of the disease.
The prognosis is defined by the following factors:
Patients with early-stage neuroendocrine carcinoma tend to have a better prognosis compared to patients with more advanced-stage cancer.
Without timely treatment, neuroendocrine carcinoma can spread to:
Complications related to treatment differ depending on the type of therapy chosen and managed by the oncology team.
Recovery depends on the stage and treatment chosen by a patient.
A person can need:
Regular follow-up is necessary since the disease can recur.
No. Despite the fact that both tumors can develop in the nasal cavity and have similarities in appearance, they come from different cells and therefore require special investigation and treatment.
No. Many people undergo chemotherapy and radiotherapy. Surgery is needed only in some specific cases.
Yes. Neuroendocrine carcinoma is an aggressive tumor with the capacity to spread to lymph nodes and other areas of the body.
Chemotherapy is an important part of the management of high-grade neuroendocrine carcinoma in most patients.
Yes, this type of cancer can recur; therefore, regular long-term follow-up is crucial.
Your follow-up schedule will depend on your disease stage and treatment, but it will typically include regular physical examinations, endoscopy, and imaging tests.
Tender Palm Super-Speciality Hospital offers advanced Neuroendocrine Carcinoma treatment in Lucknow, India, at an affordable cost. Our multidisciplinary team of experienced Head & Neck Surgical Oncologists, ENT surgeons, Medical Oncologists, Radiation Oncologists, Radiologists, and Pathologists provides accurate diagnosis and personalized treatment plans for this rare and aggressive sinonasal cancer. We offer comprehensive treatment options, including endoscopic and open skull base surgery, chemotherapy, radiation therapy, advanced imaging, image-guided biopsy, and long-term follow-up care. With state-of-the-art technology, modern infrastructure, and a patient-centred approach, our team is committed to delivering evidence-based, comprehensive care to achieve the best possible outcomes for patients with Neuroendocrine Carcinoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com